Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Melphalan Conditioning for Lymphoma ASCT
NCT02295722Phase 2Terminated
- Sponsor
- American Health Staffing Group
- Start
- Apr 2015
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), follicular lymphoma (FL), sponsored by American Health Staffing Group. Started Apr 2015; status: terminated.
02
Drugs
gemcitabine
03
Conditions
Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT02295722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02295722.